Table 3.
Genotype frequencies of the LIMK2 polymorphism in bladder cancer subgroups (Non‐muscle invasive and Muscle‐invasive groups)
| LIMK SNP | Low stage | High stage | AOR1(95%CI2) | p |
|---|---|---|---|---|
| N3(%) | N3(%) | |||
| GG | 26(33.3) | 10(16.4) | 1.0(reference) | |
| AG | 31(39.7) | 31(50.8) | 2.35(1.97–5.60) | 0.024 |
| AA | 21(26.9) | 20(32.8) | 2.70(0.91–8.02) | 0.054 |
| AA+AG(against GG) | 52(66.7) | 51(83.6) | 2.47(1.49–5.67) | 0.038 |
| GG + AG(against AA) | 57(73.1) | 41(67.2) | 0.92(0.63–2.29) | 0.452 |
1
adjusted odds ratio for age and gender.
2
95% confidence interval.
3
Numbers of people.